Biomarkers for liver fibrotic injury
    1.
    发明授权
    Biomarkers for liver fibrotic injury 有权
    肝纤维化损伤的生物标志物

    公开(公告)号:US07972785B2

    公开(公告)日:2011-07-05

    申请号:US11656389

    申请日:2007-01-23

    Abstract: The present invention provides a method for detecting liver fibrotic injury, including fibrosis and/or cirrhosis, by assaying biological samples for differential expression of at least one gene encoding a protein chosen from SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof, wherein differential expression of at least one gene suggests the presence of liver fibrosis or cirrhosis. The invention also provides a kit containing nucleic acid probes or antibodies for detecting liver fibrosis and/or cirrhosis by assaying the differential expression of proteins encoded by SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof.

    Abstract translation: 本发明提供一种检测肝纤维化损伤(包括纤维化和/或肝硬化)的方法,通过测定生物样品来鉴别至少一种编码选自SEQ ID NO:1-SEQ ID NO:63的蛋白质的基因和人直向同源物 其中至少一个基因的差异表达表明存在肝纤维化或肝硬化。 本发明还提供了一种试剂盒,其包含通过测定由SEQ ID NO:1-SEQ ID NO:63编码的蛋白质的差异表达及其人类直向同源物来检测肝纤维化和/或肝硬化的核酸探针或抗体。

    Biomarkers for liver fibrotic injury
    2.
    发明申请
    Biomarkers for liver fibrotic injury 有权
    肝纤维化损伤的生物标志物

    公开(公告)号:US20070184476A1

    公开(公告)日:2007-08-09

    申请号:US11656389

    申请日:2007-01-23

    Abstract: The present invention provides a method for detecting liver fibrotic injury, including fibrosis and/or cirrhosis, by assaying biological samples for differential expression of at least one gene encoding a protein chosen from SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof, wherein differential expression of at least one gene suggests the presence of liver fibrosis or cirrhosis. The invention also provides a kit containing nucleic acid probes or antibodies for detecting liver fibrosis and/or cirrhosis by assaying the differential expression of proteins encoded by SEQ ID NO: 1-SEQ ID NO: 63 and human orthologs thereof.

    Abstract translation: 本发明提供一种检测肝纤维化损伤(包括纤维化和/或肝硬化)的方法,通过测定生物样品来鉴别至少一种编码选自SEQ ID NO:1-SEQ ID NO:63的蛋白质的基因和人直向同源物 其中至少一个基因的差异表达表明存在肝纤维化或肝硬化。 本发明还提供了一种试剂盒,其包含通过测定由SEQ ID NO:1-SEQ ID NO:63编码的蛋白质的差异表达及其人类直向同源物来检测肝纤维化和/或肝硬化的核酸探针或抗体。

Patent Agency Ranking